318 results
Page 5 of 16
6-K
nq2unqizibt0r dtad8
7 Nov 14
Late Stage Data to be Presented at ACAAI 2014
12:00am
6-K
h4t0mmso1prsg j8u
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
d0ra77dazag8wfnuiina
8 Oct 14
Live Filing
12:00am
6-K
EX-99.1
pgk3qeyk8u5xj
12 Sep 14
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
12:00am
6-K
vamnrfskkc9za91ay10
12 Sep 14
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
12:00am
6-K
EX-99.1
u1p503yanrggia
12 Sep 14
Teva Presents Gene Expression Analysis at Joint ACTRIMS-ECTRIMS Meeting Demonstrating COPAXONE® (glatiramer acetate injection) Has a Complex Profile
12:00am
6-K
EX-99.1
p0dd1k6
11 Sep 14
Live Filing
12:00am
6-K
EX-99.1
31aq1ld1
8 Sep 14
Successful Completion of Phase Iii Program for Teva’s Reslizumab
12:00am
6-K
EX-99.1
kde12f0ogp4qb49 rap8
3 Sep 14
Teva Launches Syncaretm Home Administration Support Program for Patients on Synribo® (Omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
pmbjh9ar3uv ryvx
3 Sep 14
Live Filing
12:00am
6-K
EX-99.1
ob4q362v
2 Sep 14
Live Filing
12:00am
6-K
EX-99.1
hdmm6b sscfqa4a7yzc
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
lxohmnu197uu1mg
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
b3xnq3g51ke
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
1li0 j6plq7m
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
EX-99.1
6w3ke
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
EX-99.1
wvmx7xcqm
28 Apr 14
Live Filing
12:00am
6-K
EX-99.1
4e2l xc5f0r8ocy7
24 Apr 14
Pride-hd Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease
12:00am
6-K
EX-99.1
cxc bfj8u
21 Apr 14
Live Filing
12:00am
6-K
EX-99.1
ma0rhsho85 8rri3hl5i
31 Mar 14
Teva Announces U.s. Supreme Court Will Hear Its Appeal on Copaxone® Patent
12:00am